CL2021001698A1 - Derivados de n-(4-(oxazol-5-il)fenil)cromano-3-carboxamida y compuestos relacionados a manera de estimuladores de la producción de células precursoras de la retina para el tratamiento contra enfermedades neurorretinianas. - Google Patents
Derivados de n-(4-(oxazol-5-il)fenil)cromano-3-carboxamida y compuestos relacionados a manera de estimuladores de la producción de células precursoras de la retina para el tratamiento contra enfermedades neurorretinianas.Info
- Publication number
- CL2021001698A1 CL2021001698A1 CL2021001698A CL2021001698A CL2021001698A1 CL 2021001698 A1 CL2021001698 A1 CL 2021001698A1 CL 2021001698 A CL2021001698 A CL 2021001698A CL 2021001698 A CL2021001698 A CL 2021001698A CL 2021001698 A1 CL2021001698 A1 CL 2021001698A1
- Authority
- CL
- Chile
- Prior art keywords
- vii
- iii
- group
- chroman
- stimulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se describen nuevos compuestos y a un método para tratar una enfermedad de la retina que conlleva a la pérdida de fotorreceptores o degeneración de retina externa, que comprende que sea administrable el compuesto de la fórmula (I) (I) o una sal farmacéuticamente aceptable, una mezcla racémica, un enantiómero correspondiente o, si corresponde, un diastereómero correspondiente del mismo, en donde: A se selecciona a partir del grupo que consiste en un 5-oxazolilo, un piridin-4-ilo, un triazolilo, un oxadiazolilo, un imidazolilo y un residuo 2- metiloxazol-5-ilo, R1 y R12 se seleccionan indistintamente a partir del grupo que consiste en hidrógeno, fluoro, cloro, metoxilo, trifluorometilo, metilo y difluorometoxilo, B se selecciona a partir del grupo que consiste en un residuo de la fórmula (II), (III), (IV), (V), (VI), (VII), (VIII) y (IX) en donde, "*" denota el punto de unión al resto de la molécula. R2, R3, R4, R5, R2 I , R3 I , R4 I , R5 I , R2 II, R3 II, R4 II, R5 II, R2 III, R3 III, R4 III, R5 III, R2 IV, R3 IV, R4 IV, R5 IV, R2 V, R3 V, R4 V, R5 V, R2 VI, R3 VI, R4 VI, R5 VI, R2 VII, R3 VII, R4 VII, y R5 VII se seleccionan indistintamente a partir del grupo que consiste en hidrógeno, un alquilo lineal o ramificado que tiene 1 a 3 átomos de carbono, fluoro, cloro, bromo, metoxilo, etoxilo, propoxilo, 2,2,2-trifluorometilo y difluorometoxilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/235,429 US10807973B2 (en) | 2018-12-28 | 2018-12-28 | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021001698A1 true CL2021001698A1 (es) | 2021-12-17 |
Family
ID=69191293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021001698A CL2021001698A1 (es) | 2018-12-28 | 2021-06-24 | Derivados de n-(4-(oxazol-5-il)fenil)cromano-3-carboxamida y compuestos relacionados a manera de estimuladores de la producción de células precursoras de la retina para el tratamiento contra enfermedades neurorretinianas. |
Country Status (15)
Country | Link |
---|---|
US (2) | US10807973B2 (es) |
EP (1) | EP3902798B1 (es) |
JP (1) | JP7492964B2 (es) |
KR (1) | KR20210110652A (es) |
CN (1) | CN113227086A (es) |
AU (1) | AU2019413682B2 (es) |
BR (1) | BR112021011633A2 (es) |
CA (1) | CA3125327A1 (es) |
CL (1) | CL2021001698A1 (es) |
EA (1) | EA202191075A1 (es) |
IL (1) | IL284302A (es) |
MX (1) | MX2021007815A (es) |
PH (1) | PH12021551133A1 (es) |
SG (1) | SG11202105229TA (es) |
WO (1) | WO2020140050A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4167999A4 (en) * | 2020-06-19 | 2024-03-06 | Endogena Therapeutics Inc | NOVEL COMPOUNDS AND THEIR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF DISEASES INVOLVING THE RETINAL PIGMENTED EPITHELIUM |
US11541039B2 (en) | 2020-10-08 | 2023-01-03 | Endogena Therapeutics, Inc. | Compounds and their use as therapeutically active substances in the treatment and/or reducing signs or symptoms of diseases involving the retinal pigment epithelium |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2216439A1 (en) | 1996-09-25 | 1998-03-25 | Derek Van Der Kooy | Pharmaceuticals containing retinal stem cells |
US6342516B1 (en) | 1998-07-31 | 2002-01-29 | Nippon Soda Co., Ltd. | Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
TWI243164B (en) * | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
ES2453950T3 (es) | 2007-08-27 | 2014-04-09 | AbbVie Deutschland GmbH & Co. KG | 4-(4-Piridinil)-benzamidas y su uso como moduladores de la actividad de ROCK |
JP2011506445A (ja) * | 2007-12-13 | 2011-03-03 | アムジエン・インコーポレーテツド | γ−セクレターゼ調節剤 |
EP2234618A4 (en) | 2007-12-21 | 2011-04-27 | Scripps Research Inst | BENZOPYRANE AND ANALOGUE AS RHO KINASE INHIBITORS |
US9018202B2 (en) * | 2010-12-03 | 2015-04-28 | Allergan, Inc. | Methods for treating diseases of the retina |
US20130046003A1 (en) | 2011-07-22 | 2013-02-21 | Mohammed I. Dibas | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
WO2014079850A1 (en) | 2012-11-23 | 2014-05-30 | F. Hoffmann-La Roche Ag | Substituted heterocyclic derivatives |
DE102013110714A1 (de) | 2013-09-27 | 2015-04-02 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung einer nicht auf einer Proteinfaltungsstörung beruhenden neurodegenerativen Erkrankung |
WO2015070170A1 (en) | 2013-11-08 | 2015-05-14 | The Translational Genomics Research Institute | Compounds for cognitive enhancement and methods of use thereof |
KR20220039853A (ko) | 2014-11-07 | 2022-03-29 | 더 존스 홉킨스 유니버시티 | N-아세틸시스테인 아미드를 사용한 색소성 망막염의 치료 |
CA2986692A1 (en) | 2015-05-29 | 2016-12-08 | Edge Therapeutics, Inc. | Compositions and methods for reducing visual loss |
-
2018
- 2018-12-28 US US16/235,429 patent/US10807973B2/en active Active
-
2019
- 2019-12-27 MX MX2021007815A patent/MX2021007815A/es unknown
- 2019-12-27 JP JP2021537222A patent/JP7492964B2/ja active Active
- 2019-12-27 SG SG11202105229TA patent/SG11202105229TA/en unknown
- 2019-12-27 WO PCT/US2019/068768 patent/WO2020140050A1/en unknown
- 2019-12-27 KR KR1020217023910A patent/KR20210110652A/ko unknown
- 2019-12-27 EP EP19842725.4A patent/EP3902798B1/en active Active
- 2019-12-27 CN CN201980085766.5A patent/CN113227086A/zh active Pending
- 2019-12-27 CA CA3125327A patent/CA3125327A1/en active Pending
- 2019-12-27 EA EA202191075A patent/EA202191075A1/ru unknown
- 2019-12-27 US US17/418,019 patent/US20220089583A1/en active Pending
- 2019-12-27 BR BR112021011633-8A patent/BR112021011633A2/pt unknown
- 2019-12-27 AU AU2019413682A patent/AU2019413682B2/en active Active
-
2021
- 2021-05-18 PH PH12021551133A patent/PH12021551133A1/en unknown
- 2021-06-22 IL IL284302A patent/IL284302A/en unknown
- 2021-06-24 CL CL2021001698A patent/CL2021001698A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
SG11202105229TA (en) | 2021-07-29 |
JP7492964B2 (ja) | 2024-05-30 |
US10807973B2 (en) | 2020-10-20 |
EP3902798A1 (en) | 2021-11-03 |
WO2020140050A1 (en) | 2020-07-02 |
KR20210110652A (ko) | 2021-09-08 |
EP3902798B1 (en) | 2023-12-20 |
AU2019413682B2 (en) | 2023-11-23 |
US20220089583A1 (en) | 2022-03-24 |
AU2019413682A1 (en) | 2021-06-03 |
EA202191075A1 (ru) | 2021-10-06 |
EP3902798C0 (en) | 2023-12-20 |
PH12021551133A1 (en) | 2022-02-21 |
MX2021007815A (es) | 2021-10-01 |
IL284302A (en) | 2021-08-31 |
JP2022516087A (ja) | 2022-02-24 |
CA3125327A1 (en) | 2020-07-02 |
US20200207749A1 (en) | 2020-07-02 |
CN113227086A (zh) | 2021-08-06 |
BR112021011633A2 (pt) | 2021-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2021001698A1 (es) | Derivados de n-(4-(oxazol-5-il)fenil)cromano-3-carboxamida y compuestos relacionados a manera de estimuladores de la producción de células precursoras de la retina para el tratamiento contra enfermedades neurorretinianas. | |
RU2403251C2 (ru) | Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70 | |
AR060604A1 (es) | Nuevos arilamino n- heteroarilos como inhibidores de mek | |
AR084174A1 (es) | Compuestos de imidazol-2-benzamida utiles para el tratamiento de osteoartritis y una composicion farmaceutica | |
PH12014502866A1 (en) | Fungicidal heterocyclic carboxamides | |
RU2017116196A (ru) | 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1 | |
MX2018009944A (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico. | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
RU2012137501A (ru) | Сигма-лиганды для применения при профилактике и/или лечении послеоперационной боли | |
JP2016540742A5 (es) | ||
EA201000557A1 (ru) | Производные тетрагидрохинолина для лечения посттравматических стрессовых расстройств | |
RU2010126056A (ru) | Органические соединения | |
RU2012123154A (ru) | Способы лечения синдрома фибромиалгии | |
PE20061156A1 (es) | Derivados de benzamida como agentes inhibidores del transportador de glicina | |
JP2013509392A5 (es) | ||
PE20161369A1 (es) | Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona sustituidos con tetrazolona | |
PE20070829A1 (es) | Inhibidores cetp heterociclicos | |
EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
AR074128A1 (es) | Derivados de 4-[2-(2-fluorofenoximetil)fenil] piperidina, composiciones farmaceuticas que los contienen, metodo de preparacion, compuestos intermediarios de dicho proceso y uso de los mismos para el tratamiento de dolores neuropaticos, mal de alzheimer y otras enfermedades relacionadas con el snc. | |
MX2016008536A (es) | Derivados de fluoro-naftilo. | |
RU2012150795A (ru) | Композиция для борьбы с заболеваниями растений и ее применение описание | |
RU2019115059A (ru) | Модуляторы ror-гамма | |
JP2015536965A5 (es) | ||
JP2019523279A5 (es) | ||
RU2004139041A (ru) | Применение гетероаренкарбоксамидов в качестве дофамин-d3 лигандов для лечения заболеваний центральной нервной системы |